RIPE-KG · Version 1.1.0 · Resource

ripekg:registry-evidence/RIPEA0A4B2238CEE31171

https://w3id.org/ripe/ripe-kg/registry-evidence/RIPEA0A4B2238CEE31171

Subject	Predicate	Object
`ripekg:evaluation/RIPEA0A4B2238CEE31171`	`prov:used`	`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`rdf:type`	`rdfs:Resource`
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`rdf:type`	`owl:Thing`
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`rdf:type`	`ripe:IntegrityAssessmentEvidence`Integrity assessment evidence
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`rdf:type`	`ripe:RegistryEvidence`Registry evidence
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`rdf:type`	`tido:Evidence`
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`prov:wasAttributedTo`	`ripekg:source/clinicaltrials-gov`ClinicalTrials.gov
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`prov:wasGeneratedBy`	`ripekg:evidence-aggregation/RIPEA0A4B2238CEE31171`
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`prov:wasMemberOf`	`ripekg:research-integrity-assessment/RIPEA0A4B2238CEE31171`
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`ripe:concerns`	`ripekg:work/10.1136%2Fbmj-2025-084314`Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`ripe:isProspective`	true
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`ripe:registrationAssessmentRationale`	Registration date is on or before LLM recruitment start date.
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`ripe:registrationDate`	09-01-2024
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`ripe:registrationId`	NCT06199089
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`ripe:registrationLink`	https://clinicaltrials.gov/study/NCT06199089
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`ripe:registryName`	ClinicalTrials.gov
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`tido:supports`	`ripekg:integrity-assessment-hypothesis/RIPEA0A4B2238CEE31171-human-2-2`
`ripekg:registry-evidence/RIPEA0A4B2238CEE31171`	`tido:supports`	`ripekg:integrity-assessment-hypothesis/RIPEA0A4B2238CEE31171-inspectai-2-2`